XML 44 R29.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Jan. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Stock Options Activity The following table summarizes the activity related to the Company's stock options:
Options Outstanding
Outstanding Stock OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Life (in years)Aggregate Intrinsic Value
(in thousands)
Balance, January 31, 2021
8,871,890 $7.64 4.94$81,906 
Granted— $— 
Exercised(2,220,276)$8.65 
Forfeited or canceled(30,913)$11.33 
Balance, January 31, 2022
6,620,701 $7.28 4.32$11,723 
Vested and expected to vest6,578,465 $7.25 4.31$11,723 
Exercisable at January 31, 2022
6,420,701 $7.12 4.28$11,723 
Schedule of Nonvested Share Activity
Nonvested option activity is as follows:
OptionsWeighted-Average Grant Date Fair Value
Nonvested as of January 31, 2021
544,911 $5.55 
Granted— $— 
Vested(344,515)$5.25 
Forfeited(396)$5.95 
Balance as of January 31, 2022
200,000 $6.06 
Schedule of Nonvested RSU Activity The following table summarizes the activity related to the Company's restricted stock and restricted stock units:
OutstandingWeighted-Average Grant Date Fair Value
Balance as of January 31, 2021
9,545,352 $16.71 
Granted7,831,853 $12.94 
Vested and converted to shares(4,426,715)$15.76 
Forfeited or canceled(2,766,276)$16.09 
Balance as of January 31, 2022
10,184,214 $14.38 
Schedule of Employee Stock Purchase Plan Valuation Assumptions
The Black-Scholes option-pricing model assumptions used to calculate the fair value of shares, estimated at commencement to be purchased during an ESPP offering period were as follows:
Fiscal year ended January 31,
202220212020
Expected life (years)0.500.500.50
Expected volatility
45.54% - 59.24%
51.44% - 65.48%
42.41% - 60.86%
Dividend yield0.00%0.00%0.00%
Risk-free rate
0.05% - 0.06%
0.12% - 0.29%
1.93% - 2.52%
Schedule of Share-Based Compensation Expense The Company's stock-based compensation expense for the periods presented was as follows:
Fiscal year ended January 31,
(in thousands)202220212020
Cost of revenue$7,099 $5,724 $4,115 
Sales and marketing26,496 32,581 31,421 
Research and development20,654 17,071 13,212 
General and administrative19,231 16,918 19,022 
Total stock-based compensation expense$73,480 $72,294 $67,770